| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |